Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Precursor cell lymphoblastic leukemia-lymphoma | D054198 | — | C91.0 | 2 | — | — | — | — | 2 |
Myelodysplastic syndromes | D009190 | — | D46 | 1 | — | — | — | — | 1 |
Myeloproliferative disorders | D009196 | — | D47.1 | 1 | — | — | — | — | 1 |
Drug common name | PINOMETOSTAT |
INN | pinometostat |
Description | (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-[[[3-[2-(6-tert-butyl-1H-benzimidazol-2-yl)ethyl]cyclobutyl]-propan-2-ylamino]methyl]oxolane-3,4-diol is a 5'-deoxyribonucleoside. |
Classification | Small molecule |
Drug class | enzyme inhibitors |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CC(C)N(C[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)[C@H]1C[C@@H](CCc2nc3cc(C(C)(C)C)ccc3[nH]2)C1 |
PDB | — |
CAS-ID | 1380288-87-8 |
RxCUI | — |
ChEMBL ID | CHEMBL3414626 |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | 8V9YR09EF3 (ChemIDplus, GSRS) |